Endovascular Superficial Femoral Artery Treatment: Can it Be as Good as Bypass?

Schmieder, Gregory C.; Panneton, Jean M.

doi:10.1053/j.semvascsurg.2008.11.004

Cited by 8 publications

(5 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, endovascular in- terventions remain controversial in the treatment of lesions .15 cm, and bypass grafting remains the gold standard or comparator with the interventions at this level. [1][2][3]6,28 The argument against endovascular intervention is the reduced patency compared with saphenous vein bypass. However, endovascular therapy provides similar limb salvage, early recovery, and diminution of morbidity and mortality during the procedure compared to surgery with the added benefit of shorter hospital stays.…”

Section: Discussionmentioning

confidence: 99%

“…However, endovascular therapy provides similar limb salvage, early recovery, and diminution of morbidity and mortality during the procedure compared to surgery with the added benefit of shorter hospital stays. 3,28 With advances in endovascular technology, promising techniques have been developed for treatment of severe femoropopliteal disease, with a successful recanalization rate exceeding 80% in TASC II C/D lesions. Even with the high risk of stent fracture, some authors report that the use of stents does not hamper the use of a bypass in a future intervention.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions

Zeller

Rastan

Macharzina

et al. 2014

Journal of Endovascular Therapy

123

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions

Zeller

Rastan

Macharzina

et al. 2014

Journal of Endovascular Therapy

123

View full text Add to dashboard Cite

show abstract

“…The literature on the treatment of SFA lesions is mounting (6, 11–17). However, the assessment of patency and overall results of different treatment modalities is somewhat problematic as study designs vary considerably.…”

Section: Discussionmentioning

confidence: 99%

Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease

et al. 2013

View full text Add to dashboard Cite

Background and Aims: Treatment of occlusive femoro-popliteal artery disease has changed during the last decade because of intensive development of endovascular technology. The aim of this study was to evaluate patient treated endovascularly or surgically for femoropopliteal atherosclerotic lesions and to assess perioperative and mid-term outcome. Material and Methods: This is a retrospective analysis of consecutive patients who had undergone prosthetic above-the-knee femoro-popliteal bypass or percutaneous transluminal angioplasty and stenting of superficial femoral artery stenosis or occlusion at Tampere university hospital, finland, between January 2007 and december 2009. patients who were alive were re-evaluated in 2010. primary and secondary patency and outcomes were assessed. Results: a total of 131 patients were treated; surgically 63 patients (69 procedures) and endovascularly 68 patients (74 procedures). The mean follow-up time was 17 months (sd ± 13 months). in the late follow-up visit, 8 (18%) patients in the bypass group suffered from claudication and 9 (20%) from critical limb ischemia. The corresponding figures for the endovascular group were 20 (36%) and 8 (20%), respectively. The primary patency was 60% at 2 years in the bypass group and 73% in the endovascular group (p = 0.092); the primary assisted patency was 62% versus 76%, respectively (p = 0.068). The secondary patency was 74% in the bypass group versus 79% in the endovascular group (p = 0.487). Conclusions: according to current results following TasC ii guideline, satisfied overall mid-term results can be achieved in the treatment of superficial femoral artery atherosclerotic disease.

show abstract

“…This may also result in local sepsis and abscess formation which may also precipitate hemorrhage (2). Pseudoaneurysm formation is not a complication that is usually documented in reviews of endovascular revascularization procedures (20,21).…”

Section: Discussionmentioning

confidence: 99%

Femoral Artery Pseudoaneurysm and Sudden Death

Zhou

Langlois

Byard

2011

Journal of Forensic Sciences

View full text Add to dashboard Cite

Pseudoaneurysm formation may be a late complication of vascular grafting. A case of sudden death in an 83-year-old woman with a previous aortobifemoral bypass graft is reported that was due to spontaneous hemorrhage from a pseudoaneurysm of the graft site that had eroded through the overlying skin and subcutaneous tissues. Pseudoaneuryms do not have to be of a particularly large size for rupture to occur. Social isolation and age-related cognitive impairment may delay treatment in older individuals resulting in a lethal outcome. The elderly are also more vulnerable to serious morbidity and death under these circumstances owing to significant underlying cardiovascular and respiratory disease and/or anticoagulant medication. Rarer conditions that may cause pseudoaneurysms include tumors and vasculidites. The possibility of an infectious contribution to the pseudoaneurysm should be considered and microbiological sampling undertaken.

show abstract

Endovascular Superficial Femoral Artery Treatment: Can it Be as Good as Bypass?

Cited by 8 publications

References 36 publications

Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions

Drug-Coated Balloons vs. Drug-Eluting Stents for Treatment of Long Femoropopliteal Lesions

Comparison of above-the-knee prosthetic femoro-popliteal bypass versus percutaneous transluminal angioplasty and stenting for treatment of occlusive superficial femoral artery disease

Femoral Artery Pseudoaneurysm and Sudden Death

Contact Info

Product

Resources

About